These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15868954)

  • 41. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.
    Fu Z; Kitagawa Y; Shen R; Shah R; Mehra R; Rhodes D; Keller PJ; Mizokami A; Dunn R; Chinnaiyan AM; Yao Z; Keller ET
    Prostate; 2006 Feb; 66(3):248-56. PubMed ID: 16175585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Transplant Proc; 2008 Dec; 40(10):3470-3. PubMed ID: 19100415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An immunohistochemical study of cyclin D1 protein expression in laryngeal squamous cell carcinoma.
    Morshed K; Skomra D; Korobowicz E; Szymański M; Polz-Dacewicz M; Gołabek W
    Acta Otolaryngol; 2007 Jul; 127(7):760-9. PubMed ID: 17573573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients.
    Lee BJ; Wang SG; Choi JS; Lee JC; Goh EK; Kim MG
    Am J Clin Oncol; 2006 Apr; 29(2):163-7. PubMed ID: 16601436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2 in patients with primary laryngeal carcinoma: a tissue microarray study.
    Dong P; Li X; Yu Z; Lu G
    J Laryngol Otol; 2007 Dec; 121(12):1177-83. PubMed ID: 17888194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
    Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
    J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.
    Went P; Agostinelli C; Gallamini A; Piccaluga PP; Ascani S; Sabattini E; Bacci F; Falini B; Motta T; Paulli M; Artusi T; Piccioli M; Zinzani PL; Pileri SA
    J Clin Oncol; 2006 Jun; 24(16):2472-9. PubMed ID: 16636342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Up-regulation of CD40 with juxtacrine activity in human nonsmall lung cancer cells correlates with poor prognosis.
    Ishikawa K; Miyamoto M; Yoshioka T; Kato T; Kaji M; Ohbuchi T; Hirano S; Itoh T; Dosaka-Akita H; Kondo S
    Cancer; 2008 Aug; 113(3):530-41. PubMed ID: 18548529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
    Palapattu GS; Wu C; Silvers CR; Martin HB; Williams K; Salamone L; Bushnell T; Huang LS; Yang Q; Huang J
    Prostate; 2009 May; 69(7):787-98. PubMed ID: 19189306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
    Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
    Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD44 expression predicts local recurrence after radiotherapy in larynx cancer.
    de Jong MC; Pramana J; van der Wal JE; Lacko M; Peutz-Kootstra CJ; de Jong JM; Takes RP; Kaanders JH; van der Laan BF; Wachters J; Jansen JC; Rasch CR; van Velthuysen ML; Grénman R; Hoebers FJ; Schuuring E; van den Brekel MW; Begg AC
    Clin Cancer Res; 2010 Nov; 16(21):5329-38. PubMed ID: 20837694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of CD44 and MMP-2: possible association with histopathological features of pleuro-pulmonary solitary fibrous tumors.
    Demırağ F; Cakir E; Alpar S; Taştepe I; Kaya S
    Turk Patoloji Derg; 2011 May; 27(2):127-33. PubMed ID: 21630198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD44 family and gynaecological cancer.
    Makrydimas G; Zagorianakou N; Zagorianakou P; Agnantis NJ
    In Vivo; 2003; 17(6):633-40. PubMed ID: 14758731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of CD44 and matrix metalloproteinase-9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma.
    Yüce I; Bayram A; Cağlı S; Canöz O; Bayram S; Güney E
    Am J Otolaryngol; 2011; 32(2):141-6. PubMed ID: 20434807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the CD44 isoform v-6 (sCD44var, v6) in the saliva of patients with laryngeal carcinoma and its prognostic role.
    Trapasso S; Garozzo A; Belfiore A; Allegra E
    Cancer Biomark; 2016; 16(2):275-80. PubMed ID: 26756618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expression of E-cadherin and CD44 in laryngeal cancer].
    Kubacka M
    Otolaryngol Pol; 2002; 56(1):119-20. PubMed ID: 12053661
    [No Abstract]   [Full Text] [Related]  

  • 60. CD44--a new prognostic marker for neuroblastoma.
    Favrot MC; Combaret V; Lasset C
    N Engl J Med; 1993 Dec; 329(26):1965. PubMed ID: 7504209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.